Please be aware that BADBIR cannot accept any new registrations at baseline for patients starting Taltz after 31st July. Participants must have started treatment and provided consent before 1st August to be accepted. If participants signed consent and commenced Taltz before this date, please ensure baseline data entry is complete on the database by the end of Monday 19th August.
Please also ensure that any patients within the conventional or small molecule cohort who have switched to Taltz before 31st July are notified to us by the end of Monday 19th so we can carry out a cohort switch, even if the patient does not currently have a follow-up due. If we aren’t notified by this date, we will not be able to switch their cohort.
This affects new registrations only. Patients already within the biologic cohort switching to Taltz can be followed-up for BADBIR as normal.